RE:RE:RE:RE:RE:RE:RE:RE:Not sure why TLT is not 2.50 yet.."relative to what's out there"...Dr Kamat said recently the results from ph2 Instiladrin were the leading edge..1 yr CR 35% ..so that's why our goal post was placed where it is by the FDA.
Instiladirn ph3 completes their treatment milestone on June 1..then a 2 yr follow up.
I am confident out ph2 will out preform.
Aubrey